Featured
Last news
Modular Medical Submits Pivot Tubeless Insulin Patch Pump for FDA 510(k) Clearance
-Targets $3 Billion "Almost-Pumper" Market with First Simplified and Removable/Replaceable Insulin Patch Pump- Aims to Improve Patient and Clinician Experience for the Care of Diabetes
Jaguar Health to Hold Investor Webcast Monday, November 17 at 8:30 AM Eastern Regarding Q3 2025 Financials & Corporate Updates
Click here to registerCompany plans to file its Earnings Report on November 14, 2025 on Form 10-Q for the quarter ended September 30, 2025
NanoViricides to Present at the Pharma Partnering Summit 2025 in Boston Today, November 14th - NV-387 is Effective Against H3N2
SHELTON, CONNECTICUT / ACCESS Newswire / November 14, 2025 / NanoViricides, Inc. (NYSE American:NNVC) (the "Company"), a clinical stage leader developing revolutionary broad-spectrum antiviral drugs that the virus cannot escape, announced that it will be presenting today, Friday, November 14th, at 11:25am ET at the Pharma Partnering Summit 2025 held at the Hilton Boston Logan Airport in Boston, MA.
Tenon Medical Announces Closing of $2.85 Million At-The-Market PIPE Financing
LOS GATOS, CA / ACCESS Newswire / November 14, 2025 / Tenon Medical, Inc. (NASDAQ:TNON) ("Tenon" or the "Company"), a company transforming care for patients suffering with certain sacro-pelvic disorders, today announced the successful closing of its previously announced at-the-market private investment in public equity (the "PIPE") financing.
TRNR Reports Record Third Quarter 2025 Results with 139% YoY Growth; Reiterates 2025 Pro Forma Revenue Guidance of $80M+ To Be Driven by Completion of Sportstech Acquisition
Quarterly Results Reflect First Full Quarter Including Wattbike (Acquisition Closed July 1)Company Reports Record Quarterly Revenue of $4.8 Million; Net Loss and Loss per Diluted Share of $5.2 Million and $3.11; Quarterly Adjusted EBITDA Loss of $2.9 million, Due to Low Inventory AvailabilitySportstech Acquisition Expected to Close in 2025 Based on Key Closing Milestone AchievementsReiterates 2025 Pro Forma Revenue Guidance of more than $80 million and Fourth Quarter Profitability Guidance
Forecasted Heavy Rain Prompts Postponement of Compassion Center Coalition for Patient Rights Inaugural Hoedown to Dec. 13
Outdoor toy-drive event rescheduled to prioritize safety as Las Vegas faces 70-90% chance of rain on Saturday
Encision Reports Second Quarter Fiscal Year 2026 Results
BOULDER, CO / ACCESS Newswire / November 14, 2025 / Encision Inc. (PK:ECIA), a medical device company owning patented Active Electrode Monitoring (AEM®) Technology that prevents dangerous radiant energy burns in minimally invasive surgery, today announced financial results for its fiscal 2026 second quarter that ended September 30, 2025.
Europe court orders Poland pay damages to woman who aborted abroad
Europe's top rights court Thursday ruled that Poland had interfered with the private life of a woman who had an abortion abroad because she was unsure it was legal at home.
EU lawmakers back proxy voting for pregnant women, new mothers
Pregnant lawmakers and new mothers will get the right to vote by proxy in the European Parliament under a rule change backed Thursday by the assembly, and now headed to member states for approval.
Pakistan grants lifetime immunity to president, current army chief
Pakistan's parliament approved a sweeping constitutional amendment on Thursday granting lifetime immunity to the president as well as the current army chief, a move critics warned would erode democratic checks and judicial independence.
Electronic Caregiver Announces Breakthrough Results from National Medicare Test of Addison Care(R), Demonstrating Unprecedented Patient Engagement, High Reliability, and Scalability for Nationwide Rollout
LAS CRUCES, NEW MEXICO / ACCESS Newswire / November 13, 2025 / Electronic Caregiver, Inc. today announced outstanding clinical performance from a multi-state Medicare service test of Addison Care®, the industry's first 3D Virtual Caregiver designed to support chronically ill older adults at home with 24/7 intelligent care, guidance, and daily engagement.
Medicure To Present Financial Results on November 20, 2025 Call at 8:30 AM ET for Quarter Ended September 30, 2025
WINNIPEG, MB / ACCESS Newswire / November 13, 2025 / Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH)(OTC PINK:MCUJF), a company focused on the development and commercialization of pharmaceuticals and healthcare products for patients and prescribers in the United States market, will present Financial Results for the quarter ended September 30, 2025 via conference call on November 20, 2025 at 8:30 am Eastern Time. The Financials for the quarter ended September 30, 2025 will be filed after market close on November 19, 2025.
Mosaic Completes Offering of an Aggregate $900 Million of 3-Year and 5-Year Senior Notes
TAMPA, FL / ACCESS Newswire / November 13, 2025 / The Mosaic Company (NYSE:MOS) today announced that it has completed an underwritten public offering (the "Offering") of $500 million aggregate principal amount of 4.350 percent senior notes due January 2029 and $400 million aggregate principal amount of 4.600 percent senior notes due November 2030 (collectively, the "Notes").
Tenon(R) Medical Reports Third Quarter 2025 Financial Results
~ Record revenue of $1.2 million, a 32% year-over-year increase, reflecting record volume in Catamaran® SI Joint Fusion System procedures and the addition of SImmetry® SI Joint Fusion Product Sales ~~ SImmetry®+ alpha launch in Q4 2025 advances strategic portfolio ~~ Foundation set for sustained growth through portfolio diversification, commercial expansion and operational alignment ~~ Subsequent to quarter end the Company announced the pricing of a PIPE financing with an industry supportive investor cohort raising total gross proceeds of $2.85 million ~
CV Sciences, Inc. Reports Third Quarter 2025 Financial Results
SAN DIEGO, CA / ACCESS Newswire / November 13, 2025 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven science-backed, natural ingredients and products, today announced its financial results for the quarter ended September 30, 2025.
Aytu BioPharma Reports Fiscal 2026 First Quarter Operational and Financial Results
Total net revenue of $13.9 millionNet income of $2.0 million, or $0.21 net income per share basicAdjusted EBITDA1 of $(0.6) million, which includes EXXUA launch investments$32.6 million cash balance at September 30, 2025Company remains on track to launch EXXUA™ (gepirone) extended-release tablets ("EXXUA") in the fourth calendar quarter of 2025 as a centerpiece of its commercial efforts as it enters the over $22 billion United States prescription major depressive disorder ("MDD") marketCompany to host conference call and webcast today, November 13, 2025, at 4:30 p.m. Eastern time
Newsmax Announces Third Quarter 2025 Financial Results
Company Reports Revenues of $45.3 million, a 4.0% Year-Over-Year Increase, Outpacing Election-Year ComparisonBroadcast Revenues Increase to $36.6 Million, a 10.1% Increase Year-Over-YearNewsmax Remains the Fourth Highest-Rated Cable News Channel With Over 28 Million Quarterly Viewers
Trifecta Partners with Prado to Make Healthy Meal Delivery Eligible for HSA/FSA Use
Making Medically Approved Meals More Accessible Nationwide for People Managing Chronic Conditions
Premiere Columbus 2025 Delivers Education, Inspiration, and New Experiences for Midwest Beauty Pros
COLUMBUS, OH / ACCESS Newswire / November 13, 2025 / Premiere Show Group, the nation's leading network of beauty industry events and professional education, successfully concluded Premiere Columbus 2025, energizing the Midwest beauty community with two days of world-class education, high-energy competition, and innovative attendee experiences. Held September 14-15 at the Greater Columbus Convention Center, the show brought together 10,000 visits of licensed professionals and students alongside 129 exhibiting brands for a weekend of skill-building, discovery, and networking.
Cosmoprof North America Miami Returns for Its Third Edition, January 27-29, 2026: Staying Ahead in Beauty, Innovation, and Industry Insights
More than 800 brands and suppliers unite in Miami to showcase the future of beauty across skin care, makeup, fragrance, hair, nails, and the entire supply chain.
HPB and Coperion Partner on Next-Generation Slurry Production
New to The Street will be covering across all media.
Fast Finance Pay Corp Reports Third Quarter 2025 Financial Results
NEW YORK, NY / ACCESS Newswire / November 13, 2025 / Fast Finance Pay Corp. (OTCID:FFPP) today reported financial results for the three and nine months ended September 30, 2025, and provides a business update.
Jaguar Health Provides Recap of November 8, 2025 Presentation on Groundbreaking Results of Proof-of-Concept Study of Crofelemer for Treatment of Pediatric Intestinal Failure at NASPGHAN Annual Meeting
Crofelemer can potentially extend and save lives of microvillus inclusion disease patients, reducing the volume of the total parenteral support (PS) necessary for them to surviveGroundbreaking PS reduction of up to 37% is unprecedented; No approved treatments exist for MVID
National Rosacea Society Awards Seal of Acceptance to Sonoma Pharmaceuticals for Reliefacyn Advanced
BOULDER, CO / ACCESS Newswire / November 13, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous acid (HOCl) products for a wide range of applications, including wound care, eye care, dermatological conditions, podiatry, and animal health care, today announced that Reliefacyn® Advanced Itch-Burn-Rash-Pain Relief Hydrogel has earned the National Rosacea Society (NRS) Seal of Acceptance.
Entero's Grid AI Prepares for Major U.S. Expansion with New Leadership Appointments to Accelerate AI Infrastructure Strategy
Timed with a sharp acceleration in AI-data-center expansion, with more than $60B in new projects announced in the last 90 days.
Tivic Health Reports Findings of Clinical Optimization Trial of Non-Invasive Cervical Vagus Nerve Stimulation (ncVNS)
The study demonstrated that personalizing the stimulation parameters to each user dramatically enhanced autonomic effects
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
NEW YORK CITY, NY / ACCESS Newswire / November 13, 2025 / Protagenic Therapeutics Inc. (NASDAQ:PTIX), a biopharmaceutical company developing novel therapeutics for stress-related neuropsychiatric and neurodegenerative disorders, today announced the successful completion of enrollment and dosing in its Multiple Ascending Dose (MAD) Phase 1 study evaluating its lead compound, known as PT00114. The study, conducted in healthy volunteers, was designed to assess the safety and tolerability profile of PT00114 following multiple doses over time. With all healthy volunteers now dosed, the company has achieved a milestone in the clinical development of its proprietary peptide-based therapeutic.
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin
THE SKNJCT-003 CLINICAL STUDY EXPANSION INTO THE UNITED KINGDOM TO FURTHER ENABLE GLOBAL PATIENT RECRUITMENT AND CLINICAL DATASET TOWARD A PIVOTAL STUDY PROGRAM
Pivotree Announces Third Quarter 2025 Results
Four Consecutive Quarters of Strong Gross Margins and Operational Discipline Drive $7.2M in Adjusted EBITDA and $3.6M in Net Income Over Trailing-Twelve Months.
BMS Holdings Berhad Sets To Raise RM80.08 Million From Ace Market IPO Exercise
KUALA LUMPUR, MY / ACCESS Newswire / November 13, 2025 / BMS Holdings Berhad ("BMS Holdings" or the "Company"), a deep-rooted Malaysian retailer and distributor specialising in tiles, stone surfaces, bathware and kitchenware, successfully launched its prospectus today in conjunction with its upcoming Initial Public Offering ("IPO") and listing on the ACE Market of Bursa Malaysia Securities Berhad ("Bursa Securities").
US jury: Boeing owes $28 mn to family of Ethiopian Airlines crash victim
A US jury in the first civil trial over a fatal Boeing 737 MAX crash determined Wednesday that the aircraft manufacturing giant owes $28.45 million to the family of a newly-wed Indian victim.
Back on track: Belgian-Dutch firm rescues Berlin to Paris sleeper train
Railway fans devastated by the scrapping of a much-heralded Berlin to Paris night train can breathe again after a Belgian-Dutch cooperative stepped in Wednesday to keep the service going.